by Jessica Casebolt | Apr 13, 2023 | Life Sciences, Tea Leaves
Electronic cigarette company Juul has reached a multimillion-dollar settlement with six states and the District of Columbia to resolve multiple lawsuits alleging the company illegally targeted young people with its advertising campaigns. Without admitting to any...
by Jessica Casebolt | Apr 7, 2023 | Life Sciences, Tea Leaves
On Thursday, the U.S. Food and Drug Administration (FDA) announced its final decision to withdraw its approval of Makena, a drug approved more than a decade ago to reduce the risk of preterm birth that had been the only medication approved for the condition. The FDA...
by Jessica Casebolt | Apr 6, 2023 | Life Sciences, Tea Leaves
An experimental vaccine for respiratory syncytial virus (RSV) was found to be 82 percent effective for infants when given to pregnant mothers, according to data published Wednesday, after a spike in cases of the virus last fall. The vaccine that was developed by...
by Jessica Casebolt | Apr 5, 2023 | Life Sciences, Tea Leaves
The U.S. National Institute on Aging is funding a 6-year, up to $300 million project to build a massive Alzheimer’s research database that can track the health of Americans for decades and enable researchers to gain new insights into the disease. Last month, the...
by Jessica Casebolt | Mar 29, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration scheduled a May advisory meeting to discuss if HRA Pharma’s birth control pill should be available over the counter, an approval that would be the first of its kind from the agency. FDA advisers originally planned to review the...
by Jessica Casebolt | Mar 13, 2023 | Life Sciences, Tea Leaves
Researchers have found long-term evidence that actively monitoring localized prostate cancer is a safe alternative to immediate surgery or radiation. A study published in the New England Journal of Medicine directly compared the three approaches of surgery to remove...
Recent Comments